On Sept. 9, 2020, Pfizer and BioNTech announced that they had submitted an amended protocol to the FDA…
On Sept. 9, 2020, Pfizer and BioNTech announced preliminary preclinical data in mouse and non-human primate models from…
On Sept. 9, 2020, iBio announced that it had selected IBIO-201, its LicKMï¾™-ubunit vaccine, as its leading candidate…
On Sept. 9, 2020, NanoString Technologies announced the formation of the GeoMx Translational Leadership Network (GTLN). The GTLN…
On Sept. 8, 2020, the CEOs of AstraZeneca, BioNTech, GlaxoSmithKline, Johnson & Johnson, Merck, Moderna, Novavax, Pfizer, and…
On Sept. 8, 2020, RedHill Biopharma announced that opaganib demonstrated potent inhibition of SARS-CoV-2, the virus that causes…
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
On Sept. 8, 2020, Vaxart announced pre-publication of a manuscript titled ﾓPreclinical studies of a recombinant adenoviral mucosal…
On Sept. 8, 2020, LabCorpï¾® announced the launch of the first testing method to simultaneously detect COVID-19, influenza…
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
On Sept. 8, 2020, DiaSorin Molecular announced that it had received FDA Clearance for its Simplexaï¾™ Flu A/B…
On Sept. 4, 2020, the University of Oxford researchers have found that natural infection with COVID-19 produces a…
On Sept. 4, 2020, Roche announced that the cobasï¾® SARS-CoV-2 & Influenza A/B Test for use on the…
On Sept. 4, 2020, the University of Oxford researchers found that natural infection with COVID-19 produces a robust…
On Sept. 4, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD),…
On Sept. 4, 2020, CureVac announced that it had received notification from the German Federal Ministry of Education…
On Sept. 3, 2020, RedHill Biopharma announced the selection of opaganib, a proprietary, first-in-class, orally-administered, sphingosine kinase-2 (SK2)…
On Sept. 3, 2020, Humanigen announced the first case-control data of lenzilumab in severe COVID-19 demonstrated an 80%…
On Sept. 3, 2020, the U.S Department of Defense announced that five locations were identified to participate in…
On Sept. 3, 2020, Sanofi and GSK announced the start of the Phase 1/2 clinical trial for their…
On Sept. 3, 2020, ADMA Biologics announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA, a proprietary, fully-validated ELISA…
On Sept. 3, 2020, Oregon Health & Science University (OHSU) announced that for the first time, early research…
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ï¾·RNA (OR-100) collection device was included along with other…
On Sept. 3, 2020, researchers from the Virginia Tech Helmet Lab announced the development of a football helmet…
On Sept. 3, 2020, a team of Virginia Tech researchers announced that they will begin testing wastewater at…
On Sept. 2, 2020, the NIH announced $129.3 million in scale-up and manufacturing support for a new set…
On Sept. 2, 2020, Mesoblast announced that it had received ethics approval to include Australian hospitals in the…
On Sept. 2, 2020, the U.S. Army Medical Materiel Development Activity reported it was working to develop a…
On Sept. 2, 2020, Broad Institute of MIT and Harvard announced it had partnered with 108 public and…
On Sept. 2, 2020, Novavax announced the publication in The New England Journal of Medicine of Phase 1…